Skip to content

Monte Rosa Therapeutics, Inc.: filings

Every Monte Rosa Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 21 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026381120001193125-26-336711
10-Q2026-05-07fiscal Q1 202638820001193125-26-210358
10-K2026-03-17fiscal FY 202540820001193125-26-109360
10-Q2025-11-06fiscal Q3 2025381150001193125-25-268045
10-Q2025-08-07fiscal Q2 2025391130000950170-25-104550
10-Q2025-05-08fiscal Q1 202537790000950170-25-066372
10-K2025-03-20fiscal FY 202438780000950170-25-042344
10-Q2024-11-07fiscal Q3 2024371110000950170-24-122780
10-Q2024-08-08fiscal Q2 2024391100000950170-24-093296
10-Q2024-05-09fiscal Q1 202437800000950170-24-056288
10-K2024-03-14fiscal FY 202339800000950170-24-031150
10-Q2023-11-09fiscal Q3 2023381120000950170-23-061995
10-Q2023-08-10fiscal Q2 2023371070000950170-23-040959
10-Q2023-05-11fiscal Q1 202336770000950170-23-021201
10-K2023-03-16fiscal FY 202238770000950170-23-008440
10-Q2022-11-10fiscal Q3 2022381080000950170-22-024447
10-Q2022-08-11fiscal Q2 2022371020000950170-22-016844
10-Q2022-05-11fiscal Q1 202234710000950170-22-009324
10-K2022-03-29fiscal FY 202131630000950170-22-004927
10-Q2021-11-10fiscal Q3 202131890000950170-21-004138
10-Q2021-08-12fiscal Q2 202131850000950170-21-001372

Inspect the source

Entity
Monte Rosa Therapeutics, Inc. / CIK 0001826457
Captured
2026-09-21T17:29:10.378Z
SEC response SHA-256
0a4a92fc3008d9e64736e7d0fd4da85bd1c7eaeca46286ae26b1364a7e47bbd8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001826457.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))